News Releases Year: - Any -20192018201720162015201420132012 Items per page 102550 10/29/18 Summary TogglePresentation of Additional Analyses of Clearside’s PEACHTREE Clinical Trial Data Further Supports Potential of XIPERE™ in Treating Uveitic Macular Edema PDF Version 10/25/18 Summary ToggleClearside Biomedical Appoints Thomas A. Ciulla, M.D., MBA as Chief Medical Officer PDF Version 10/22/18 Summary ToggleCLEARSIDE, XIPERE™ and PEACHTREE to be Front and Center at AAO 2018 PDF Version 10/19/18 Summary ToggleClearside Biomedical Appoints Veteran Supply Chain Executive, Thomas Crawford, as Vice President, Supply Chain PDF Version 09/26/18 Summary ToggleClearside Biomedical Appoints Jeffrey Edwards to Board of Directors PDF Version 09/18/18 Summary TogglePositive PEACHTREE Data to be Highlighted at EURETINA 2018 PDF Version 09/13/18 Summary ToggleData From Clearside Biomedical’s Pivotal Phase 3 PEACHTREE Clinical Trial in Macular Edema Associated with Non-Infectious Uveitis to be Presented at the Retina Society 51st Annual Scientific Meeting PDF Version 09/12/18 Summary ToggleClearside Biomedical Appoints Viral Kansara as Vice President, Discovery PDF Version 09/11/18 Summary ToggleClearside Biomedical Appoints Accomplished Pharmaceutical Industry Legal Executive, Leslie Zacks, as General Counsel and Chief Compliance Officer PDF Version 09/10/18 Summary ToggleClearside Biomedical to Participate in 2018 Janney Healthcare Conference PDF Version Pagination First page First Previous page Page 2 Current page 3 Page 4 Page 5 Next page Last page Last
